Example: Heart Attack

Search clinical trials for: Machine learning algorithm

Total 10000 results

NCT02979639

Completed

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

Herpes Zoster
NCT03556566

Unknown

Open Label Immunotherapy Trial for Ovarian Cancer (V3-OVA)

Ovarian Cancer
NCT00287469

Completed

A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.

Hepatitis
NCT02189603

Completed

Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

Hepatitis E
NCT00440297

Completed

Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)

Hepatitis B Virus Infection
NCT00334607

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Infections, Rotavirus
NCT00382772

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Infections, Rotavirus
NCT00139347

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus
NCT00380211

Completed

Safety and Immunogenicity of FluLaval™ TR and Fluarix® (Influenza Vaccines) in Young and Older Adults

Influenza
NCT00836953

Completed

Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®

Influenza
NCT01984983

Completed

Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers

Venezuelan Equine Encephalitis Virus Infection
NCT00503529

Completed

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Encephalitis, Tick-Borne
NCT02382900

Unknown

Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City

Human Papilloma Virus
NCT02330003

Completed

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

Healthy
NCT01966224

Completed

A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects

Allergic Rhinoconjunctivitis
NCT01658696

Completed

Efficacy of Candidate Malaria Vaccines in Senegalese Adults

Malaria
NCT01587365

Completed

Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins

Atherosclerosis
NCT00378976

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

HIV Infection | Sexually Transmitted Diseases | Herpes Simplex
NCT01698177

Unknown

Optimizing Influenza Vaccination in Surgical Oncology Patients

Influenza
NCT00316706

Completed

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Cervical Intraepithelial Neoplasia | Papillomavirus Infection
NCT00999206

Completed

Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine

Influenza
NCT00471133

Completed

Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation

Intraocular Melanoma | Melanoma (Skin)
NCT01301703

Unknown

Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid Arthritis

Rheumatoid Arthritis
NCT00936468

Completed

Safety, Tolerability and Immunogenicity of Fluzone® With and Without JVRS-100 in Elderly Subjects

Influenza
NCT00828828

Completed

Antibody Response to Influenza Vaccine in Patients With Sarcoidosis (IVS)

Pulmonary Sarcoidosis
NCT04012073

Terminated

Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome (IPERPEEP)

Respiratory Distress Syndrome, Adult
NCT05616754

Recruiting

A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)

COVID-19
NCT05087368

Not yet recruiting

Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19) (TP-SCB-2019001)

Covid19
NCT04049864

Recruiting

DNA Vaccination Against Neuroblastoma

Relapsed Neuroblastoma
NCT06065176

Completed

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection (BEEHIVE)

COVID-19 | SARS CoV 2 Infection | Vaccine-Preventable Diseases | Upper Respiratory Tract Infection | Upper Respiratory Disease
NCT04543877

Completed

WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study

Inflammation | Typhoid Fever | Vaccine | Intestinal Permeability
NCT03821272

Completed

A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients

Head and Neck Cancer
NCT04543383

Completed

A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants

Healthy
NCT04523246

Completed

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents (NH-Shingrix)

Herpes Zoster | Corona Virus Infection | Allergy and Immunology
NCT00972309

Completed

A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

Prostate Neoplasms | Prostate Specific Antigens
NCT00019734

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)
NCT03091660

Active, not recruiting

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Stage 0is Bladder Urothelial Carcinoma | Stage I Bladder Urothelial Carcinoma | Stage 0 Bladder Urothelial Carcinoma
NCT02149225

Completed

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

Glioblastoma
NCT03112174

Completed

Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL) (SYMPATICO)

Mantle-Cell Lymphoma
NCT02070003

Completed

Perioperative Recovery of Moods, Opioids, and Pain Trial (PROMPT) (PROMPT)

Opioid Cessation
NCT03916835

Completed

MUSIDORE PED Study (MUSIDORE)

Pain Management | Music Therapy
NCT06461455

Completed

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses

Presbyopia | Astigmatism
NCT01379768

Completed

Study of the Cell Response in the Tear Film After Overnight Contact Lens Wear (CORNWALL)

White Blood Cells
NCT07160244

Recruiting

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Healthy
NCT03133923

Active, not recruiting

Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Epidemic Parotitis,Mumps
NCT02114060

Completed

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

Genital Herpes Simplex Type 2
NCT00693966

Completed

Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females

Infections, Papillomavirus
NCT01339923

Completed

A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According to Different Immunization Schedules and to Healthy Children Aged 2 to 10 Years

Meningococcal Disease | Meningococcal Meningitis
NCT07142356

Recruiting

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension
NCT06751966

Recruiting

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Colorectal Cancer (CRC)

Search clinical trials for: Machine learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations